Literature DB >> 17993631

MRI features of breast cancer: a correlation study with HER-2 receptor.

G Agrawal, J H Chen, H M Baek, D Hsiang, R S Mehta, O Nalcioglu, M-Y Su.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993631     DOI: 10.1093/annonc/mdm477

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?

Authors:  S Bahri; J-H Chen; H J Yu; A Kuzucan; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2008-03-05       Impact factor: 32.976

2.  A robust coregistration method for in vivo studies using a first generation simultaneous PET/MR scanner.

Authors:  Thomas S C Ng; Daniel Procissi; Yibao Wu; Russell E Jacobs
Journal:  Med Phys       Date:  2010-05       Impact factor: 4.071

3.  Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.

Authors:  J-H Chen; R S Mehta; H-M Baek; K Nie; H Liu; M Q Lin; H J Yu; O Nalcioglu; M-Y Su
Journal:  NMR Biomed       Date:  2010-09-22       Impact factor: 4.044

4.  Choline as a biomarker for cell proliferation: do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers?

Authors:  Hyeon-Man Baek; Jeon-Hor Chen; Orhan Nalcioglu; Min-Ying Su
Journal:  Int J Cancer       Date:  2008-09-01       Impact factor: 7.396

5.  Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon.

Authors:  Garima Agrawal; Min-Ying Su; Orhan Nalcioglu; Stephen A Feig; Jeon-Hor Chen
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.